{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T22:32:15Z","timestamp":1765837935898,"version":"build-2065373602"},"reference-count":101,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015629","name":"Jerome L. Greene Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015629","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23 AR071473"],"award-info":[{"award-number":["K23 AR071473"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001845","name":"Scleroderma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001845","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.rdc.2023.01.007","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T22:09:23Z","timestamp":1680732563000},"page":"319-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Gastrointestinal Tract Considerations: Part II"],"prefix":"10.1016","volume":"49","author":[{"given":"Alannah","family":"Quinlivan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsuzsanna H.","family":"McMahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Bong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.rdc.2023.01.007_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semarthrit.2007.10.010","article-title":"The immunobiology of systemic sclerosis","volume":"38","author":"Gu","year":"2008","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.007_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/MCG.0b013e318042d625","article-title":"Gastric and enteric involvement in progressive systemic sclerosis","volume":"42","author":"Ebert","year":"2008","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.007_bib3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/RHU.0000000000000428","article-title":"Prevalence and severity of depression and anxiety in patients with systemic sclerosis: an epidemiologic survey and investigation of clinical correlates","volume":"23","author":"Faezi","year":"2017","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.007_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/rheumatology\/keq296","article-title":"Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis. Research Support, N.I.H., Extramural","volume":"50","author":"Bodukam","year":"2011","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.007_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semarthrit.2016.02.005","article-title":"Impaired quality of life in systemic sclerosis and patient perception of the disease: a large international survey","volume":"46","author":"Frantz","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.007_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MEG.0b013e32831dac75","article-title":"Lower gastrointestinal symptoms and quality of life in patients with systemic sclerosis: a population-based study","volume":"21","author":"Franck-Larsson","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.007_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semarthrit.2011.01.002","article-title":"Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort","volume":"41","author":"Sharif","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.007_bib8","first-page":"150","article-title":"Fatigue in systemic sclerosis: a systematic review. Systematic Review","volume":"36 Suppl 113","author":"Basta","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2023.01.007_bib9","doi-asserted-by":"crossref","first-page":"doy136","DOI":"10.1093\/dote\/doy136","article-title":"The impact of gastroesophageal reflux disease symptoms in scleroderma: effects on sleep quality","volume":"32","author":"Horsley-Silva","year":"2019","journal-title":"Dis Esophagus"},{"issue":"11","key":"10.1016\/j.rdc.2023.01.007_bib10","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.007_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/2397198319891282","article-title":"Gastrointestinal involvement in systemic sclerosis: effects on morbidity and mortality and new therapeutic approaches","volume":"6","author":"Hoffmann-Vold","year":"2019","journal-title":"Journal of Scleroderma and Related Disorders"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.007_bib12","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/rheumatology\/key350","article-title":"Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality","volume":"58","author":"Richard","year":"2019","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.rdc.2023.01.007_bib13","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1007\/s00296-011-1988-6","article-title":"Profile of gastrointestinal involvement in patients with systemic sclerosis. Original Paper","volume":"32","author":"Schmeiser","year":"2012","journal-title":"Rheumatol Int: Clinical and Experimental Investigations"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.007_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/003655299750026434","article-title":"Bowel problems in patients with systemic sclerosis","volume":"34","author":"Trezza","year":"1999","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"10.1016\/j.rdc.2023.01.007_bib15","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/cid\/cix669","article-title":"2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea","volume":"65","author":"Shane","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rdc.2023.01.007_bib16","first-page":"11","article-title":"Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis. Review","volume":"11","author":"Feng","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.007_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-018-1874-0","article-title":"Small intestinal bacterial overgrowth in systemic sclerosis: a review of the literature. Systematic Review","volume":"311","author":"Polkowska-Pruszynska","year":"2019","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"10.1016\/j.rdc.2023.01.007_bib18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/RHU.0000000000000626","article-title":"Gastrointestinal involvement in systemic sclerosis: an update","volume":"24","author":"Miller","year":"2018","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.007_bib19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2174\/1573397113666170425145405","article-title":"Gastrointestinal dysmotility and infections in systemic sclerosis- an indian scenario. observational study","volume":"14","author":"Adarsh","year":"2018","journal-title":"Curr Rheumatol Rev"},{"issue":"2 Suppl 76","key":"10.1016\/j.rdc.2023.01.007_bib20","first-page":"57","article-title":"Associations between a scleroderma-specific gastrointestinal instrument and objective tests of upper gastrointestinal involvements in systemic sclerosis","volume":"31","author":"Bae","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2023.01.007_bib21","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/gutjnl-2017-315909","article-title":"Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology","volume":"67","author":"Arasaradnam","year":"2018","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.rdc.2023.01.007_bib22","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3390\/nu13051393","article-title":"What are the pearls and pitfalls of the dietary management for chronic diarrhoea?","volume":"13","author":"O\u2019Brien","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.rdc.2023.01.007_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819878950","article-title":"Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions","volume":"12","author":"Cangemi","year":"2019","journal-title":"Therapeutic Advances in Gastroenterology"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.007_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/nu13010088","article-title":"Effects of coffee and its components on the gastrointestinal tract and the brain\u2013gut axis","volume":"13","author":"Iriondo-DeHond","year":"2020","journal-title":"Nutrients"},{"issue":"39","key":"10.1016\/j.rdc.2023.01.007_bib25","doi-asserted-by":"crossref","first-page":"e1601","DOI":"10.1097\/MD.0000000000001601","article-title":"Fructose malabsorption in systemic sclerosis. observational study","volume":"94","author":"Marie","year":"2015","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/j.rdc.2023.01.007_bib26","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/apt.13810","article-title":"Lactose malabsorption in systemic sclerosis","volume":"44","author":"Marie","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.007_bib27","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/0148607115597883","article-title":"Medical Nutrition Therapy for Patients With Advanced Systemic Sclerosis (MNT PASS): A Pilot Intervention Study. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't","volume":"41","author":"Doerfler","year":"2017","journal-title":"Journal of Parenteral & Enteral Nutrition"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.007_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2036.2007.03557.x","article-title":"lactose intolerance in clinical practice\u2013myths and realities","volume":"27","author":"Lomer","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.rdc.2023.01.007_bib29","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jada.2006.07.010","article-title":"Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management","volume":"106","author":"Shepherd","year":"2006","journal-title":"J\u00a0Am Diet Assoc"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.007_bib30","article-title":"ACG clinical guideline: management of irritable bowel syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Journal of the American College of Gastroenterology"},{"issue":"6","key":"10.1016\/j.rdc.2023.01.007_bib31","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s10620-007-0065-1","article-title":"A\u00a0systematic review of diagnostic tests for small intestinal bacterial overgrowth","volume":"53","author":"Khoshini","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.rdc.2023.01.007_bib32","first-page":"1304","article-title":"Continued experience with the xylose breath test-evidence that the small bowel culture as the gold standard for bacterial overgrowth may be tarnished","volume":"80","author":"Tillman","year":"1981","journal-title":"Gastroenterology"},{"issue":"5728","key":"10.1016\/j.rdc.2023.01.007_bib33","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.rdc.2023.01.007_bib34","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/apt.12456","article-title":"Small intestinal bacterial overgrowth\u2013prevalence, clinical features, current and developing diagnostic tests, and treatment","volume":"38","author":"Grace","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.007_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5056\/jnm19113","article-title":"Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: a systematic review with meta-analysis","volume":"26","author":"Losurdo","year":"2020","journal-title":"Journal of Neurogastroenterology and Motility"},{"issue":"3","key":"10.1016\/j.rdc.2023.01.007_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/rheumatology\/34.3.265","article-title":"Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Comparative Study Research Support, Non-U.S. Gov't","volume":"34","author":"Kaye","year":"1995","journal-title":"Br J Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2023.01.007_bib37","first-page":"1","article-title":"Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference","volume":"29","author":"Gasbarrini","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.rdc.2023.01.007_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/diagnostics10080587","article-title":"The role of fecal calprotectin in patients with systemic sclerosis and small intestinal bacterial overgrowth (SIBO)","volume":"10","author":"Polkowska-Pruszynska","year":"2020","journal-title":"Diagnostics"},{"issue":"6","key":"10.1016\/j.rdc.2023.01.007_bib39","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.autrev.2015.01.018","article-title":"Fecal calprotectin in systemic sclerosis and review of the literature","volume":"14","author":"Marie","year":"2015","journal-title":"Review. Autoimmunity Reviews."},{"issue":"3","key":"10.1016\/j.rdc.2023.01.007_bib40","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3748\/wjg.v22.i3.917","article-title":"Inflammatory bowel disease imaging: current practice and future directions","volume":"22","author":"Kilcoyne","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.007_bib41","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for diagnostic assessment in ibd part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"Journal of Crohn's and Colitis"},{"issue":"03","key":"10.1016\/j.rdc.2023.01.007_bib42","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1055\/s-0043-125329","article-title":"EFSUMB recommendations and clinical guidelines for intestinal ultrasound (GIUS) in inflammatory bowel diseases","volume":"39","author":"Maconi","year":"2018","journal-title":"Ultraschall in der Medizin-European Journal of Ultrasound"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.007_bib43","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/ecco-jcc\/jjaa216","article-title":"Expert consensus on optimal acquisition and development of the international bowel ultrasound segmental activity score [IBUS-SAS]: a reliability and inter-rater variability study on intestinal ultrasonography in crohn\u2019s disease","volume":"15","author":"Novak","year":"2021","journal-title":"Journal of Crohn's and Colitis."},{"issue":"5","key":"10.1016\/j.rdc.2023.01.007_bib44","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.semarthrit.2012.09.004","article-title":"Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients","volume":"42","author":"Gemignani","year":"2013","journal-title":"Clinical Trial. Seminars in Arthritis & Rheumatism"},{"issue":"5","key":"10.1016\/j.rdc.2023.01.007_bib45","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1572-0241.2007.01758.x","article-title":"Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication","volume":"103","author":"Parodi","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.rdc.2023.01.007_bib46","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/MCG.0b013e3181c64c90","article-title":"A\u00a0combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test","volume":"44","author":"Low","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.007_bib47","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0000000000000814","article-title":"Probiotics for preventing and treating small intestinal bacterial overgrowth","volume":"51","author":"Zhong","year":"2017","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.007_bib48","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s10620-019-05830-0","article-title":"Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis. Clinical Trial Research Support, Non-U.S. Gov't","volume":"65","author":"Garcia-Collinot","year":"2020","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.007_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jgh3.12045","article-title":"Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors versus proton pump inhibitors plus prokinetics","volume":"2","author":"Revaiah","year":"2018","journal-title":"JGH open"},{"issue":"21","key":"10.1016\/j.rdc.2023.01.007_bib50","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1056\/NEJM199111213252102","article-title":"Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma","volume":"325","author":"Soudah","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.007_bib51","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1572-0241.2001.03636.x","article-title":"Long-term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function","volume":"96","author":"Madrid","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.rdc.2023.01.007_bib52","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/MCG.0000000000000257","article-title":"Small intestinal transit time is delayed in small intestinal bacterial overgrowth","volume":"49","author":"Roland","year":"2015","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.007_bib53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/17474124.2020.1708718","article-title":"An approach to the diagnosis and management of Rome IV functional disorders of chronic constipation","volume":"14","author":"Aziz","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.rdc.2023.01.007_bib54","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.rdc.2023.01.007_bib55","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2036.2006.02804.x","article-title":"Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Research Support, Non-U.S. Gov't Review Systematic Review","volume":"23","author":"Sallam","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rdc.2023.01.007_bib56","first-page":"16","article-title":"The relationship between gastrointestinal transit, Medsger GI severity, and UCLA GIT 2.0 symptoms in patients with systemic sclerosis","volume":"16","author":"McMahan","year":"2020","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.rdc.2023.01.007_bib57","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1053\/gast.2000.20390","article-title":"American Gastroenterological Association medical position statement: Guidelines on constipation","volume":"119","author":"Locke","year":"2000","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.007_bib58","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/00365521.2019.1568544","article-title":"Exercise therapy in patients with constipation: a systematic review and meta-analysis of randomized controlled trials","volume":"54","author":"Gao","year":"2019","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.007_bib59","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/gut.2010.227132","article-title":"Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis","volume":"60","author":"Ford","year":"2011","journal-title":"Gut"},{"issue":"6 Suppl 86","key":"10.1016\/j.rdc.2023.01.007_bib60","first-page":"214","article-title":"Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis","volume":"32","author":"Hansi","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.007_bib61","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/ajg.2014.187","article-title":"American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation","volume":"109","author":"Ford","year":"2014","journal-title":"Journal of the American College of Gastroenterology"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.007_bib62","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12876-021-01738-0","article-title":"Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosis","volume":"21","author":"Dein","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"10.1016\/j.rdc.2023.01.007_bib63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11894-019-0699-0","article-title":"Colonic and anorectal manifestations of systemic sclerosis. Review","volume":"21","author":"Sattar","year":"2019","journal-title":"Curr Gastroenterol Rep"},{"issue":"12","key":"10.1016\/j.rdc.2023.01.007_bib64","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.crad.2008.06.011","article-title":"Blinded comparison of faecal loading on plain radiography versus radio-opaque marker transit studies in the assessment of constipation","volume":"63","author":"Cowlam","year":"2008","journal-title":"Clin Radiol"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.007_bib65","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bpg.2010.11.001","article-title":"What is necessary to diagnose constipation?","volume":"25","author":"Rao","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.rdc.2023.01.007_bib66","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cgh.2009.01.017","article-title":"Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation","volume":"7","author":"Rao","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.007_bib67","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.semarthrit.2017.12.007","article-title":"Pyridostigmine for the treatment of gastrointestinal symptoms in systemic sclerosis. Research Support, Non-U.S. Gov't","volume":"48","author":"Ahuja","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.007_bib68","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13075-017-1340-y","article-title":"Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study. Randomized Controlled Trial Research Support, Non-U.S. Gov't","volume":"19","author":"Vigone","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.rdc.2023.01.007_bib69","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2036.2011.04602.x","article-title":"Systematic review: the effects of fibre in the management of chronic idiopathic constipation","volume":"33","author":"Suares","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.007_bib70","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrrheum.2012.191","article-title":"Systemic sclerosis\u2014challenges for clinical practice","volume":"9","author":"McMahan","year":"2013","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.007_bib71","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1586\/egh.13.22","article-title":"Systemic sclerosis and the gut","volume":"7","author":"Butt","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.007_bib72","first-page":"581","article-title":"Clinical correlates of faecal incontinence in systemic sclerosis: Identifying therapeutic avenues","volume":"56","author":"Richard","year":"2017","journal-title":"Rheumatology"},{"issue":"15","key":"10.1016\/j.rdc.2023.01.007_bib73","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3748\/wjg.v27.i15.1553","article-title":"Diagnostic approach to faecal incontinence: what test and when to perform?","volume":"27","author":"Sbeit","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.rdc.2023.01.007_bib74","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/BF02236199","article-title":"Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence","volume":"42","author":"Rockwood","year":"1999","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"10.1016\/j.rdc.2023.01.007_bib75","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/ajg.2014.190","article-title":"ACG clinical guideline: management of benign anorectal disorders","volume":"109","author":"Wald","year":"2014","journal-title":"Journal of the American College of Gastroenterology"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.007_bib76","doi-asserted-by":"crossref","first-page":"e13679","DOI":"10.1111\/nmo.13679","article-title":"The International Anorectal Physiology Working Group (IAPWG) recommendations: Standardized testing protocol and the London classification for disorders of anorectal function","volume":"32","author":"Carrington","year":"2020","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.rdc.2023.01.007_bib77","doi-asserted-by":"crossref","first-page":"402583","DOI":"10.5402\/2011\/402583","article-title":"Anorectal motility and sensation abnormalities and its correlation with anorectal symptoms in patients with systemic sclerosis: a preliminary study","volume":"2011","author":"Sallam","year":"2011","journal-title":"ISRN Gastroenterol"},{"issue":"6","key":"10.1016\/j.rdc.2023.01.007_bib78","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3109\/03009742.2011.579575","article-title":"Faecal incontinence in patients with systemic sclerosis: is an impaired internal anal sphincter the only cause?","volume":"40","author":"Fynne","year":"2011","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2023.01.007_bib79","first-page":"63","article-title":"Esophageal and anorectal involvement in systemic sclerosis: a systematic assessment with high resolution manometry","volume":"34 Suppl 100","author":"Luciano","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2023.01.007_bib80","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4253\/wjge.v7.i6.575","article-title":"Endoanal ultrasonography in fecal incontinence: current and future perspectives","volume":"7","author":"Albuquerque","year":"2015","journal-title":"World J Gastrointest Endosc"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2023.01.007_bib81","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1590\/s0004-2803.201800000-49","article-title":"Functional and anatomical analysis of the anorectum of female scleroderma patients at a center for pelvic floor disorders","volume":"1","author":"Pinto","year":"2018","journal-title":"Arq Gastroenterol"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.007_bib82","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1148\/radiology.208.2.9680588","article-title":"Fecal incontinence in scleroderma: assessment of the anal sphincter with thin-section endoanal MR imaging","volume":"208","author":"deSouza","year":"1998","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.rdc.2023.01.007_bib83","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.crad.2021.04.014","article-title":"Multimodality imaging of the gastrointestinal manifestations of scleroderma","volume":"76","author":"Delaney","year":"2021","journal-title":"Clin Radiol"},{"issue":"10","key":"10.1016\/j.rdc.2023.01.007_bib84","first-page":"3255","article-title":"Physiotherapy for prevention and treatment of fecal incontinence in women\u2014systematic review of methods","volume":"9","author":"Mazur-Bialy","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"3","key":"10.1016\/j.rdc.2023.01.007_bib85","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.cgh.2020.03.050","article-title":"Factors associated with response to anorectal biofeedback therapy in patients with fecal incontinence","volume":"19","author":"Mazor","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.rdc.2023.01.007_bib86","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1080\/00365521.2016.1218537","article-title":"Efficacy of anorectal biofeedback in scleroderma patients with fecal incontinence: a case\u2013control study","volume":"51","author":"Collins","year":"2016","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"10.1016\/j.rdc.2023.01.007_bib87","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/bjs.4796","article-title":"Systematic review of sacral nerve stimulation for faecal incontinence and constipation","volume":"91","author":"Jarrett","year":"2004","journal-title":"Journal of British Surgery"},{"issue":"5","key":"10.1016\/j.rdc.2023.01.007_bib88","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00384-018-2976-z","article-title":"Sacral nerve stimulation versus percutaneous tibial nerve stimulation for faecal incontinence: a systematic review and meta-analysis","volume":"33","author":"Simillis","year":"2018","journal-title":"Int J Colorectal Dis"},{"issue":"12","key":"10.1016\/j.rdc.2023.01.007_bib89","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/ajg.2012.330","article-title":"Transcutaneous electrical tibial nerve stimulation in the treatment of fecal incontinence: a randomized trial (CONSORT 1a)","volume":"107","author":"Leroi","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"10004","key":"10.1016\/j.rdc.2023.01.007_bib90","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0140-6736(15)60314-2","article-title":"Percutaneous tibial nerve stimulation versus sham electrical stimulation for the treatment of faecal incontinence in adults (CONFIDeNT): a double-blind, multicentre, pragmatic, parallel-group, randomised controlled trial","volume":"386","author":"Knowles","year":"2015","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.rdc.2023.01.007_bib91","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/codi.12969","article-title":"Lack of effect of sacral nerve stimulation for incontinence in patients with systemic sclerosis","volume":"17","author":"Butt","year":"2015","journal-title":"Colorectal Dis"},{"issue":"6","key":"10.1016\/j.rdc.2023.01.007_bib92","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/gut.51.6.881","article-title":"Sacral nerve stimulation for faecal incontinence due to systemic sclerosis","volume":"51","author":"Kenefick","year":"2002","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2023.01.007_bib93","doi-asserted-by":"crossref","first-page":"A206","DOI":"10.1136\/gutjnl-2014-307263.443","article-title":"PWE-183 preliminary significant findings from a randomised control trial of posterior tibial nerve stimulation in systemic sclerosis associated faecal incontinence","volume":"63","author":"Butt","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.rdc.2023.01.007_bib94","first-page":"603","article-title":"Reliability, validity, and minimally important differences of the UCLA scleroderma clinical trial consortium gastrointestinal tract (UCLA SCTC 2.0) instrument","volume":"10","author":"Khanna","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2023.01.007_bib95","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/ajg.2014.237","article-title":"Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales","volume":"109","author":"Spiegel","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.rdc.2023.01.007_bib96","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/acr.22337","article-title":"Construct validity of the patient-reported outcomes measurement information system gastrointestinal symptom scales in systemic sclerosis","volume":"66","author":"Nagaraja","year":"2014","journal-title":"Arthritis Care Res"},{"issue":"583","key":"10.1016\/j.rdc.2023.01.007_bib97","first-page":"41","article-title":"Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD)","author":"Wiklund","year":"1998","journal-title":"Eur J Surg Suppl"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.007_bib98","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3899\/jrheum.180004","article-title":"Longitudinal assessment of patient-reported outcome measures in systemic sclerosis patients with gastroesophageal reflux disease - scleroderma clinical trials consortium. Research Support, Non-U.S. Gov't","volume":"46","author":"McMahan","year":"2019","journal-title":"J\u00a0Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2023.01.007_bib99","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s11136-004-8751-3","article-title":"Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL","volume":"13","author":"de la Loge","year":"2004","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.007_bib100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02050307","article-title":"Etiology and management of fecal incontinence","volume":"36","author":"Jorge","year":"1993","journal-title":"Dis Colon Rectum"},{"issue":"9","key":"10.1016\/j.rdc.2023.01.007_bib101","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/rheumatology\/ker153","article-title":"Internal anal sphincter atrophy in patients with systemic sclerosis. Research Support, Non-U.S. Gov't","volume":"50","author":"Thoua","year":"2011","journal-title":"Rheumatology"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X23000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X23000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:31:33Z","timestamp":1760182293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X23000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0889857X23000078"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2023.01.007","relation":{},"ISSN":["0889-857X"],"issn-type":[{"type":"print","value":"0889-857X"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal Tract Considerations: Part II","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2023.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}